Michelle

📢 Calling all gastroenterologists trained in Europe! Take part in our ESNM Young Members–endorsed survey on training in Neurogastroenterology & Motility. Help us map gaps & shape future education across Europe 🌍 👉 redcap.link/NGMsurvey #YoungESNM #NGM @esnm_eu @my_ueg

Best Abstract Presentation Prize at #UEGW2024🥇 Honored to present our Experience Sampling Method study on triggers of abdominal pain in #IBS patients with data from @DiscoverieEU

First unofficial Young ESNM Happy hour during #UEGweek2024 in Vienna! Stat tuned with #NGM #GItwitter @esnm_eu @my_ueg @RomeFoundation

The official @MUMC_GI portrait at @my_ueg in Vienna 🇦🇹 #UEGW #UEGW2024 @MujagicZlatan @WeertsZsaZsa @MichelleBosman_ @AssmannSade

The @my_ueg countdown begins! Just 1⃣2⃣ more days! Check out our @MUMC_GI schedule 😇 with @MujagicZlatan @AssmannSade @MichelleBosman_ @Sylvestergroen #RoselSturkenboom and @IBS_Maastricht Hope to see you all in Vienna 🇦🇹📯

Our psychometric validation study on the experience sampling method in IBS is published in @AmJGastro! @VorkLisa @IBS_Maastricht 🔗journals.lww.com/ajg/abstract/9… #GItwitter #IBS #ESM

Excited to share that we have been awarded Best Poster at #IBSdays2024 for our Experience Sampling Method study with preliminary results of @DiscoverieEU on dynamic triggers in #IBS patients

#Young_ESNM enjoying IBS Days 2024! @MelchiorChloe @giomara89 @MichelleBosman_

Today at #DDW2024 I show the results of our PoC RCT investigating the role of A2-milk versus conventional milk on acute gastrointestinal complains in IBS patients. Visit me at poster Tu1661. #IBS

Today at #DDW2024 I show the results of our Experience Sampling Method psychometric validation study showing that IBS patients report higher symptom burden at the end of the day compared to real-time assessment. Visit me at poster Tu1662. #IBS #ESM

Today at #NeuroGASTRO2023 several Consortium members as @VHIR_ 🇪🇸 , @UCCpsychiatry 🇮🇪, @MUMC_GI 🇳🇱, @labgas_kuleuven 🇧🇪, @Unibo 🇮🇹 and @UMF_Cluj 🇷🇴 - have attended/moderated/presented the preliminary results of the #DISCOvERIE project. Sharing is caring for #research & #patients.

Happy to have been part of the NeuroGastro TANDEM! Lot of networking, constructive environment and new friends! A special thank to our mentor @MelchiorChloe @MichelleBosman_ @esnm_eu

🚨 Check out the paper by @MichelleBosman_ & @WeertsZsaZsa now out in @AGA_CGH on the socioeconomic 💰 impact of #IBS 🗝️ findings: *⃣Productivity loss is the main contributor to costs *⃣Direct 🏥 costs mostly related to mental healthcare 🔓cghjournal.org/article/S1542-… #GITwitter

Excited to share our meta-analysis on placebo response in💊trials in #FD - @NGMJournal Placebo response: ~39% ❗️Entry criterion with minimal level of symptom severity to⬇️placebo responses onlinelibrary.wiley.com/doi/10.1111/nm… #GITwitter @IBS_Maastricht @MagnusSimren @NJTalley01 @MUMC_GI

#Digestive Disease Days 2022 🇳🇱 Our very own @MichelleBosman_ touches on the socioeconomic impact of #IBS in the #Netherlands 💎 Quarterly mean total cost per IBS patient €2156 💶❗️ 💡Largely driven by costs related to #productivity loss

Onze onderzoekers van de afdeling MDL vragen zich af of online hypnotherapie een goede en kosteneffectieve therapie is voor het Prikkelbare Darm Syndroom (PDS). Daarvoor zoeken ze mensen tussen 16 en 75 jaar, die bekend zijn met PDS. Meer weten: mumc.nl/patient-bezoek…

Can't wait for #UEGW2021 to start! @my_ueg @UEGWeekLive @UEGJournal Just 2⃣ more weeks! Check out the full programme here 👉🏾ueg.eu/week/science/p… including contributions from the @IBS_Maastricht team. Very proud! 😇 @MujagicZlatan @MichelleBosman_ @AlleleynAnnick & others

Welke factoren spelen een rol bij het ontstaan van Prikkelbare Darm Syndroom? De @MaastrichtU @IBS_Maastricht onderzoekt dit! Doe je mee? Meer info en aanmelden: pdsb.nl/discoverie/ #dtv #onderzoek #PDS

🚨 A placebo response of 27% for the global improvement endpoint in #IBS-trials. Find out how to minimize the high placebo response rates in IBS in our meta-analysis in @LancetGastroHep. 👉 thelancet.com/journals/langa… #IBS #placebo #GITwitter

Our meta-analysis on #placebo response in #IBS by @MichelleBosman_ in @LancetGastroHep featured in @medpagetoday😇 medpagetoday.com/gastroenterolo…